The Diagnostic Imaging ultrasound modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of ultrasound across the healthcare continuum, from cardiovascular, breast, abdominal, neurological imaging, and more, including point-of-care ultrasound.
November 20th 2024
The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Breast elasticity imaging improves specificity
November 27th 2006Elasticity imaging with ultrasound allows radiologists to accurately distinguish benign from malignant breast lesions, according to a study presented at the RSNA meeting on Monday. Researchers using the technique correctly identified both cancerous and benign lesions in nearly all of the cases studied.
Colleges converge on cardiovascular imaging quality
November 22nd 2006Officials from the American College of Radiology and the American College of Cardiology, along with other interested stakeholders, have published a consensus report defining quality for all cardiovascular imaging modalities. They say that the focus on quality in cardiovascular imaging has been less intense than in other areas of cardiovascular medicine.
Contrast ultrasound holds ground in blunt abdominal trauma
November 1st 2006Mounting evidence indicates that, far from fading away, ultrasound could retain a role in the triage and follow-up of patients presenting to the emergency room with traumatic abdominal solid organ injury. Prospective data from University of California researchers validate earlier studies showing that contrast-enhanced sonography outperforms conventional sonography and complements CT’s role in this setting.
FDA tightens grip on handheld ultrasound
October 25th 2006The FDA has denied a request for over-the-counter sales of handheld Doppler fetoscopes. The American College of Radiology and the American Institute of Ultrasound in Medicine, which have aggressively lobbied to stop unwarranted use of ultrasound technology by nonmedical personnel, hailed the decision.
3D echocardiography gauges heart mass loss in astronauts
October 23rd 2006Ultrasound is no stranger to space travel. Typically, however, the imaging modality has been used to evaluate musculoskeletal problems associated with near-weightless conditions. A new effort launched by the National Aeronautics and Space Administration uses live 3D ultrasound and advanced postprocessing to evaluate the effects of microgravity on astronauts’ hearts.
Radiologists pledge to recapture sonography
October 19th 2006Going from gloom to bloom at a seminar yesterday, radiology luminaries dissected the latest practice trends, technological developments, and clinical applications in ultrasound use and turf. Their conclusions, to be published in a major radiology journal, should indicate if radiologists will choose to relinquish control of ultrasound for good or reclaim a modality that could thrive in the hands of experts through the next decade.
GE unveils lightweight, high-performance ultrasound
October 13th 2006GE Healthcare launched the latest salvo in its campaign to migrate high-performance capabilities to cost-challenged corners of medicine this week, releasing its lightweight, high-powered Logiq P5 at the Society of Diagnostic Medical Sonography conference in Denver.
Data support islet cell therapy for diabetes
October 2nd 2006An international multicenter trial has validated the Edmonton Protocol for islet cell infusion as a fitting treatment alternative for certain patients suffering from type 1 diabetes. Results appeared in the Sept. 28 issue of The New England Journal of Medicine.